Pacific Biosciences of California (PACB) — Cash Flow Quality Index
Pacific Biosciences of California (PACB) has a Cash Flow Quality Index of -12.93x as of December 2024. Operating cash flow of $-30.65 Million is below net income of $2.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PACB cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pacific Biosciences of California Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for Pacific Biosciences of California across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Pacific Biosciences of California reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Pacific Biosciences of California (2020–2020)
Year-by-year earnings quality comparison for Pacific Biosciences of California. For live market cap and the full company financial profile, see market cap of Pacific Biosciences of California.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 0.66x | $19.50 Million | $29.40 Million | — |